{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:02:51Z","timestamp":1793084571125,"version":"4.5.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T00:00:00Z","timestamp":1666656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T00:00:00Z","timestamp":1666656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2020M683107"],"award-info":[{"award-number":["2020M683107"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81902679"],"award-info":[{"award-number":["81902679"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021A1515010760"],"award-info":[{"award-number":["2021A1515010760"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Metastatic breast carcinoma is commonly considered during differential diagnosis when metastatic disease is detected in females. In addition to the tumor morphology and documented clinical history, sensitive and specific immunohistochemical (IHC) markers such as GCDFP-15, mammaglobin, and GATA3 are helpful for determining breast origin. However, these markers are reported to show lower sensitivity in certain subtypes, such as triple-negative breast cancer (TNBC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>\n                      Using bioinformatics analyses, we identified a potential diagnostic panel to determine breast origin: matrix Gla protein (MGP), transcriptional repressor GATA binding 1 (TRPS1), and GATA-binding protein 3 (GATA3). We compared MGP, TRPS1, and GATA3 expression in different subtypes of breast carcinoma of (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091201) using IHC. As a newly identified marker, MGP expression was also evaluated in solid tumors (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20092384) and normal tissues (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091351) from different organs.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      MGP and TRPS1 had comparable positive expression in HER2-positive (91.2% vs. 92.0%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.79) and TNBC subtypes (87.3% vs. 91.2%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.18). GATA3 expression was lower than MGP (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) or TRPS1 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), especially in HER2-positive (77.0%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and TNBC (43.3%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) subtypes. TRPS1 had the highest positivity rate (97.9%) in metaplastic TNBCs, followed by MGP (88.6%), while only 47.1% of metaplastic TNBCs were positive for GATA3. When using MGP, GATA3, and TRPS1 as a novel IHC panel, 93.0% of breast carcinomas were positive for at least two markers, and only 9 cases were negative for all three markers. MGP was detected in 36 cases (3.0%) that were negative for both GATA3 and TRPS1. MGP showed mild-to-moderate positive expression in normal hepatocytes, renal tubules, as well as 31.1% (99\/318) of hepatocellular carcinomas. Rare cases (0.6\u20135%) had focal MGP expression in renal, ovarian, lung, urothelial, and cholangiocarcinomas.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings suggest that MGP is a newly identified sensitive IHC marker to support breast origin. MGP, TRPS1, and GATA3 could be applied as a reliable diagnostic panel to determine breast origin in clinical practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13058-022-01569-1","type":"journal-article","created":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T09:02:47Z","timestamp":1666688567000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Matrix Gla protein (MGP), GATA3, and TRPS1: a novel diagnostic panel to determine breast origin"],"prefix":"10.1186","volume":"24","author":[{"given":"Tian","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyou","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanzhong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiewei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongzhen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiehua","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,25]]},"reference":[{"key":"1569_CR1","unstructured":"Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975\u20132018, National Cancer Institute. Bethesda, MD, https:\/\/seer.cancer.gov\/csr\/1975_2018\/."},{"issue":"6","key":"1569_CR2","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1158\/1055-9965.EPI-16-0889","volume":"26","author":"AB Mariotto","year":"2017","unstructured":"Mariotto AB, Etzioni R, Hurlbert M, Penberthy L, Mayer M. Estimation of the number of women living with metastatic breast cancer in the United States. Cancer Epidemiol Biomark Prev. 2017;26(6):809\u201315.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"1","key":"1569_CR3","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1186\/s12885-019-6311-z","volume":"19","author":"R Wang","year":"2019","unstructured":"Wang R, Zhu Y, Liu X, et al. The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer. BMC Cancer. 2019;19(1):1091.","journal-title":"BMC Cancer"},{"issue":"1","key":"1569_CR4","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","volume":"5","author":"N Harbeck","year":"2019","unstructured":"Harbeck N, Penault-Llorca F, Cortes J, et al. Breast cancer. Nat Rev Dis Primers. 2019;5(1):66.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"1569_CR5","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/his.12877","volume":"68","author":"AM Gown","year":"2016","unstructured":"Gown AM, Fulton RS, Kandalaft PL. Markers of metastatic carcinoma of breast origin. Histopathology. 2016;68(1):86\u201395.","journal-title":"Histopathology"},{"issue":"9","key":"1569_CR6","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1097\/PAS.0b013e3182556def","volume":"36","author":"S Barak","year":"2012","unstructured":"Barak S, Wang Z, Miettinen M. Immunoreactivity for calretinin and keratins in desmoid fibromatosis and other myofibroblastic tumors: a diagnostic pitfall. Am J Surg Pathol. 2012;36(9):1404\u20139.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"1569_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/PAS.0b013e3182a0218f","volume":"38","author":"M Miettinen","year":"2014","unstructured":"Miettinen M, McCue PA, Sarlomo-Rikala M, et al. GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors. Am J Surg Pathol. 2014;38(1):13\u201322.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"1569_CR8","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1309\/AJCP8H2VBDSCIOBF","volume":"142","author":"BZ Clark","year":"2014","unstructured":"Clark BZ, Beriwal S, Dabbs DJ, Bhargava R. Semiquantitative GATA-3 immunoreactivity in breast, bladder, gynecologic tract, and other cytokeratin 7-positive carcinomas. Am J Clin Pathol. 2014;142(1):64\u201371.","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"1569_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.anndiagpath.2014.12.001","volume":"19","author":"SM Wendroth","year":"2015","unstructured":"Wendroth SM, Mentrikoski MJ, Wick MR. GATA3 expression in morphologic subtypes of breast carcinoma: a comparison with gross cystic disease fluid protein 15 and mammaglobin. Ann Diagn Pathol. 2015;19(1):6\u20139.","journal-title":"Ann Diagn Pathol"},{"issue":"1","key":"1569_CR10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1309\/TDP92PQLDE2HLEET","volume":"127","author":"R Bhargava","year":"2007","unstructured":"Bhargava R, Beriwal S, Dabbs DJ. Mammaglobin vs GCDFP-15: an immunohistologic validation survey for sensitivity and specificity. Am J Clin Pathol. 2007;127(1):103\u201313.","journal-title":"Am J Clin Pathol"},{"issue":"11","key":"1569_CR11","first-page":"1221","volume":"22","author":"FR Fritzsche","year":"2007","unstructured":"Fritzsche FR, Thomas A, Winzer KJ, et al. Co-expression and prognostic value of gross cystic disease fluid protein 15 and mammaglobin in primary breast cancer. Histol Histopathol. 2007;22(11):1221\u201330.","journal-title":"Histol Histopathol"},{"key":"1569_CR12","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1186\/1471-2407-14-546","volume":"14","author":"S Darb-Esfahani","year":"2014","unstructured":"Darb-Esfahani S, von Minckwitz G, Denkert C, et al. Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypes. BMC Cancer. 2014;14:546.","journal-title":"BMC Cancer"},{"issue":"5","key":"1569_CR13","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/modpathol.2010.38","volume":"23","author":"M Yang","year":"2010","unstructured":"Yang M, Nonaka D. A study of immunohistochemical differential expression in pulmonary and mammary carcinomas. Mod Pathol. 2010;23(5):654\u201361.","journal-title":"Mod Pathol"},{"issue":"6","key":"1569_CR14","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/pin.12278","volume":"65","author":"Y Hattori","year":"2015","unstructured":"Hattori Y, Yoshida A, Yoshida M, et al. Evaluation of androgen receptor and GATA binding protein 3 as immunohistochemical markers in the diagnosis of metastatic breast carcinoma to the lung. Pathol Int. 2015;65(6):286\u201392.","journal-title":"Pathol Int"},{"issue":"2","key":"1569_CR15","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1365-2559.2012.04344.x","volume":"62","author":"L Huo","year":"2013","unstructured":"Huo L, Zhang J, Gilcrease MZ, et al. Gross cystic disease fluid protein-15 and mammaglobin A expression determined by immunohistochemistry is of limited utility in triple-negative breast cancer. Histopathology. 2013;62(2):267\u201374.","journal-title":"Histopathology"},{"issue":"11","key":"1569_CR16","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1016\/j.humpath.2014.06.022","volume":"45","author":"G Krings","year":"2014","unstructured":"Krings G, Nystrom M, Mehdi I, et al. Diagnostic utility and sensitivities of GATA3 antibodies in triple-negative breast cancer. Hum Pathol. 2014;45(11):2225\u201332.","journal-title":"Hum Pathol"},{"issue":"2","key":"1569_CR17","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/his.12645","volume":"67","author":"L Huo","year":"2015","unstructured":"Huo L, Gong Y, Guo M, et al. GATA-binding protein 3 enhances the utility of gross cystic disease fluid protein-15 and mammaglobin A in triple-negative breast cancer by immunohistochemistry. Histopathology. 2015;67(2):245\u201354.","journal-title":"Histopathology"},{"issue":"5","key":"1569_CR18","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1309\/AJCP0Q9UQTEESLHN","volume":"141","author":"H Liu","year":"2014","unstructured":"Liu H, Shi J, Prichard JW, Gong Y, Lin F. Immunohistochemical evaluation of GATA-3 expression in ER-negative breast carcinomas. Am J Clin Pathol. 2014;141(5):648\u201355.","journal-title":"Am J Clin Pathol"},{"issue":"22","key":"1569_CR19","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1093\/bioinformatics\/btv377","volume":"31","author":"M Rahman","year":"2015","unstructured":"Rahman M, Jackson LK, Johnson WE, et al. Alternative preprocessing of RNA-Sequencing data in The Cancer Genome Atlas leads to improved analysis results. Bioinformatics. 2015;31(22):3666\u201372.","journal-title":"Bioinformatics"},{"issue":"1","key":"1569_CR20","doi-asserted-by":"publisher","first-page":"7205","DOI":"10.1038\/s41598-018-25357-0","volume":"8","author":"T Du","year":"2018","unstructured":"Du T, Zhu L, Levine KM, et al. Invasive lobular and ductal breast carcinoma differ in immune response, protein translation efficiency and metabolism. Sci Rep. 2018;8(1):7205.","journal-title":"Sci Rep"},{"issue":"3","key":"1569_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2021.100067","volume":"1","author":"A Thennavan","year":"2021","unstructured":"Thennavan A, Beca F, Xia Y, et al. Molecular analysis of TCGA breast cancer histologic types. Cell Genom. 2021;1(3): 100067.","journal-title":"Cell Genom"},{"issue":"12","key":"1569_CR22","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"issue":"17","key":"1569_CR23","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.95703","volume":"2","author":"N Priedigkeit","year":"2017","unstructured":"Priedigkeit N, Watters RJ, Lucas PC, et al. Exome-capture RNA sequencing of decade-old breast cancers and matched decalcified bone metastases. JCI Insight. 2017;2(17): e95703.","journal-title":"JCI Insight"},{"issue":"4","key":"1569_CR24","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1093\/jnci\/djy110","volume":"111","author":"D Vare\u0161lija","year":"2019","unstructured":"Vare\u0161lija D, Priedigkeit N, Fagan A, et al. Transcriptome characterization of matched primary breast and brain metastatic tumors to detect novel actionable targets. J Natl Cancer Inst. 2019;111(4):388\u201398.","journal-title":"J Natl Cancer Inst"},{"key":"1569_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41523-019-0114-x","volume":"5","author":"KM Levine","year":"2019","unstructured":"Levine KM, Priedigkeit N, Basudan A, et al. FGFR4 overexpression and hotspot mutations in metastatic ER+ breast cancer are enriched in the lobular subtype. NPJ Breast Cancer. 2019;5:19.","journal-title":"NPJ Breast Cancer"},{"issue":"7","key":"1569_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7): e47.","journal-title":"Nucleic Acids Res"},{"issue":"7605","key":"1569_CR27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature18003","volume":"534","author":"P Mertins","year":"2016","unstructured":"Mertins P, Mani DR, Ruggles KV, et al. Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016;534(7605):55\u201362.","journal-title":"Nature"},{"key":"1569_CR28","doi-asserted-by":"publisher","first-page":"545","DOI":"10.5858\/arpa.2019-0904-SA","volume":"144","author":"KH Allison","year":"2020","unstructured":"Allison KH, Hammond MEH, Dowsett M, et al. Estrogen and progesterone receptor testing in breast cancer: American society of clinical oncology\/college of American pathologists guideline update. Arch Pathol Lab Med. 2020;144:545\u201363.","journal-title":"Arch Pathol Lab Med"},{"key":"1569_CR29","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.5858\/arpa.2018-0902-SA","volume":"142","author":"AC Wolff","year":"2018","unstructured":"Wolff AC, Hammond MEH, Allison KH, et al. Human epidermal growth factor receptor 2 testing in breast cancer: American society of clinical oncology\/college of American pathologists clinical practice guide focused update. Arch Pathol Lab Med. 2018;142:1364\u201382.","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"1569_CR30","first-page":"138","volume":"8","author":"W Remmele","year":"1987","unstructured":"Remmele W, Stegner HE. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe. 1987;8(3):138\u201340.","journal-title":"Pathologe"},{"issue":"4","key":"1569_CR31","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/s41379-020-00692-8","volume":"34","author":"D Ai","year":"2021","unstructured":"Ai D, Yao J, Yang F, et al. TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer. Mod Pathol. 2021;34(4):710\u20139.","journal-title":"Mod Pathol"},{"issue":"5","key":"1569_CR32","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.cell.2006.09.048","volume":"127","author":"H Kouros-Mehr","year":"2006","unstructured":"Kouros-Mehr H, Slorach EM, Sternlicht MD, Werb Z. GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell. 2006;127(5):1041\u201355.","journal-title":"Cell"},{"issue":"2","key":"1569_CR33","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/ncb1530","volume":"9","author":"ML Asselin-Labat","year":"2007","unstructured":"Asselin-Labat ML, Sutherland KD, Barker H, et al. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat Cell Biol. 2007;9(2):201\u20139.","journal-title":"Nat Cell Biol"},{"issue":"2","key":"1569_CR34","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ceb.2008.02.003","volume":"20","author":"H Kouros-Mehr","year":"2008","unstructured":"Kouros-Mehr H, Kim JW, Bechis SK, Werb Z. GATA-3 and the regulation of the mammary luminal cell fate. Curr Opin Cell Biol. 2008;20(2):164\u201370.","journal-title":"Curr Opin Cell Biol"},{"key":"1569_CR35","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.humpath.2015.09.035","volume":"48","author":"R Asch-Kendrick","year":"2016","unstructured":"Asch-Kendrick R, Cimino-Mathews A. The role of GATA3 in breast carcinomas: a review. Hum Pathol. 2016;48:37\u201347.","journal-title":"Hum Pathol"},{"issue":"8","key":"1569_CR36","doi-asserted-by":"publisher","first-page":"4435","DOI":"10.21873\/anticanres.12745","volume":"38","author":"N Emmanuel","year":"2018","unstructured":"Emmanuel N, Lofgren KA, Peterson EA, et al. Mutant GATA3 actively promotes the growth of normal and malignant mammary cells. Anticancer Res. 2018;38(8):4435\u201341.","journal-title":"Anticancer Res"},{"issue":"3","key":"1569_CR37","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/PAS.0000000000001824","volume":"46","author":"B Parkinson","year":"2022","unstructured":"Parkinson B, Chen W, Shen T, et al. TRPS1 expression in breast carcinomas: focusing on metaplastic breast carcinomas. Am J Surg Pathol. 2022;46(3):415\u201323.","journal-title":"Am J Surg Pathol"},{"issue":"22","key":"1569_CR38","first-page":"00085","volume":"S0046\u20138177","author":"EC Yoon","year":"2022","unstructured":"Yoon EC, Wang G, Parkinson B, et al. TRPS1, GATA3, and SOX10 expression in triple-negative breast carcinoma. Hum Pathol. 2022;S0046\u20138177(22):00085\u201395.","journal-title":"Hum Pathol"},{"issue":"Suppl 1","key":"1569_CR39","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41379-020-00697-3","volume":"34","author":"A Cimino-Mathews","year":"2021","unstructured":"Cimino-Mathews A. Novel uses of immunohistochemistry in breast pathology: interpretation and pitfalls. Mod Pathol. 2021;34(Suppl 1):62\u201377.","journal-title":"Mod Pathol"},{"issue":"5","key":"1569_CR40","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1007\/s004390050420","volume":"99","author":"J Nardmann","year":"1997","unstructured":"Nardmann J, Tranebjaerg L, Horsthemke B, L\u00fcdecke HJ. The tricho-rhino-phalangeal syndromes: frequency and parental origin of 8q deletions. Hum Genet. 1997;99(5):638\u201343.","journal-title":"Hum Genet"},{"issue":"1","key":"1569_CR41","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ydbio.2009.01.012","volume":"328","author":"M Wuelling","year":"2009","unstructured":"Wuelling M, Kaiser FJ, Buelens LA, et al. Trps1, a regulator of chondrocyte proliferation and differentiation, interacts with the activator form of Gli3. Dev Biol. 2009;328(1):40\u201353.","journal-title":"Dev Biol"},{"issue":"7","key":"1569_CR42","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1093\/emboj\/20.7.1715","volume":"20","author":"TH Malik","year":"2001","unstructured":"Malik TH, Shoichet SA, Latham P, et al. Transcriptional repression and developmental functions of the atypical vertebrate GATA protein TRPS1. EMBO J. 2001;20(7):1715\u201325.","journal-title":"EMBO J"},{"issue":"5","key":"1569_CR43","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.celrep.2018.10.023","volume":"25","author":"RM Witwicki","year":"2018","unstructured":"Witwicki RM, Ekram MB, Qiu X, et al. TRPS1 is a lineage-specific transcriptional dependency in breast cancer. Cell Rep. 2018;25(5):1255\u201367.","journal-title":"Cell Rep"},{"issue":"10","key":"1569_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.108814","volume":"34","author":"J Yang","year":"2021","unstructured":"Yang J, Liu X, Huang Y, et al. TRPS1 drives heterochromatic origin refiring and cancer genome evolution. Cell Rep. 2021;34(10): 108814.","journal-title":"Cell Rep"},{"key":"1569_CR45","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/0006-291X(83)91663-7","volume":"117","author":"PA Price","year":"1983","unstructured":"Price PA, Urist MR, Otawara Y. Matrix Gla protein, a new gamma-carboxyglutamic acid-containing protein which is associated with the organic matrix of bone. Biochem Biophys Res Commun. 1983;117:765\u201371.","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"1569_CR46","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.1016\/S0021-9258(18)60639-8","volume":"263","author":"JE Hale","year":"1988","unstructured":"Hale JE, Fraser JD, Price PA. The identification of matrix Gla protein in cartilage. J Biol Chem. 1988;263(12):5820\u20134.","journal-title":"J Biol Chem"},{"issue":"6","key":"1569_CR47","first-page":"1764","volume":"82","author":"R Wallin","year":"1999","unstructured":"Wallin R, Cain D, Sane DC. Matrix Gla protein synthesis and gamma-carboxylation in the aortic vessel wall and proliferating vascular smooth muscle cells\u2013a cell system which resembles the system in bone cells. Thromb Haemost. 1999;82(6):1764\u20137.","journal-title":"Thromb Haemost"},{"issue":"10","key":"1569_CR48","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.2174\/0929867325666180716104159","volume":"27","author":"G Bj\u00f8rklund","year":"2020","unstructured":"Bj\u00f8rklund G, Svanberg E, Dadar M, et al. The role of Matrix Gla Protein (MGP) in vascular calcification. Curr Med Chem. 2020;27(10):1647\u201360.","journal-title":"Curr Med Chem"},{"issue":"4","key":"1569_CR49","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3390\/nu10040415","volume":"10","author":"H Barrett","year":"2018","unstructured":"Barrett H, O\u2019Keeffe M, Kavanagh E, et al. Is Matrix Gla protein associated with vascular calcification? A systematic review. Nutrients. 2018;10(4):415.","journal-title":"Nutrients"},{"issue":"5","key":"1569_CR50","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1002\/1878-0261.12652","volume":"14","author":"M Wang","year":"2020","unstructured":"Wang M, Chen L, Chen Y, et al. Intracellular matrix Gla protein promotes tumor progression by activating JAK2\/STAT5 signaling in gastric cancer. Mol Oncol. 2020;14(5):1045\u201358.","journal-title":"Mol Oncol"},{"issue":"4","key":"1569_CR51","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/ijc.2910520406","volume":"52","author":"EN Levedakou","year":"1992","unstructured":"Levedakou EN, Strohmeyer TG, Effert PJ, Liu ET. Expression of the matrix Gla protein in urogenital malignancies. Int J Cancer. 1992;52(4):534\u20137.","journal-title":"Int J Cancer"},{"issue":"10","key":"1569_CR52","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1002\/mc.23079","volume":"58","author":"C Gong","year":"2019","unstructured":"Gong C, Zou J, Zhang M, et al. Upregulation of MGP by HOXC8 promotes the proliferation, migration, and EMT processes of triple-negative breast cancer. Mol Carcinog. 2019;58(10):1863\u201375.","journal-title":"Mol Carcinog"},{"issue":"26","key":"1569_CR53","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1038\/onc.2010.147","volume":"29","author":"PM Kuzontkoski","year":"2010","unstructured":"Kuzontkoski PM, Mulligan-Kehoe MJ, Harris BT, Israel MA. Inhibitor of DNA binding-4 promotes angiogenesis and growth of glioblastoma multiforme by elevating matrix GLA levels. Oncogene. 2010;29(26):3793\u2013802.","journal-title":"Oncogene"},{"issue":"4","key":"1569_CR54","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3892\/mmr_00000131","volume":"2","author":"K Yoshimura","year":"2009","unstructured":"Yoshimura K, Takeuchi K, Nagasaki K, et al. Prognostic value of matrix Gla protein in breast cancer. Mol Med Rep. 2009;2(4):549\u201353.","journal-title":"Mol Med Rep"},{"issue":"3","key":"1569_CR55","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/PAS.0000000000001216","volume":"43","author":"E Laurent","year":"2019","unstructured":"Laurent E, Begueret H, Bonhomme B, et al. SOX10, GATA3, GCDFP15, androgen receptor, and mammaglobin for the differential diagnosis between triple-negative breast cancer and TTF1-negative lung adenocarcinoma. Am J Surg Pathol. 2019;43(3):293\u2013302.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"1569_CR56","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10549-020-05818-9","volume":"184","author":"C Aphivatanasiri","year":"2020","unstructured":"Aphivatanasiri C, Li J, Chan R, et al. Combined SOX10 GATA3 is most sensitive in detecting primary and metastatic breast cancers: a comparative study of breast markers in multiple tumors. Breast Cancer Res Treat. 2020;184(1):11\u201321.","journal-title":"Breast Cancer Res Treat"},{"key":"1569_CR57","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.humpath.2022.01.002","volume":"121","author":"J Wang","year":"2022","unstructured":"Wang J, Wang WL, Sun H, et al. Expression of TRPS1 in phyllodes tumor and sarcoma of the breast. Hum Pathol. 2022;121:73\u201380.","journal-title":"Hum Pathol"},{"issue":"4","key":"1569_CR58","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/path.4740","volume":"239","author":"C Zandueta","year":"2016","unstructured":"Zandueta C, Ormaz\u00e1bal C, Perurena N, et al. Matrix-Gla protein promotes osteosarcoma lung metastasis and associates with poor prognosis. J Pathol. 2016;239(4):438\u201349.","journal-title":"J Pathol"},{"issue":"20","key":"1569_CR59","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1200\/JCO.2009.25.9820","volume":"28","author":"H Kennecke","year":"2010","unstructured":"Kennecke H, Yerushalmi R, Woods R, et al. Metastatic behavior of breast cancer subtypes. J Clin Oncol. 2010;28(20):3271\u20137.","journal-title":"J Clin Oncol"},{"issue":"10","key":"1569_CR60","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/BF01221195","volume":"122","author":"T Ozaki","year":"1996","unstructured":"Ozaki T, Hillmann A, Lindner N, et al. Metastasis of chondrosarcoma. J Cancer Res Clin Oncol. 1996;122(10):625\u20138.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1569_CR61","doi-asserted-by":"publisher","first-page":"4747","DOI":"10.2147\/OTT.S107638","volume":"9","author":"T Nakamura","year":"2016","unstructured":"Nakamura T, Matsumine A, Yamada S, et al. Oncological outcome after lung metastasis in patients presenting with localized chondrosarcoma at extremities: Tokai Musculoskeletal Oncology Consortium study. Onco Targets Ther. 2016;9:4747\u201351.","journal-title":"Onco Targets Ther"},{"issue":"10","key":"1569_CR62","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1200\/JCO.2003.08.132","volume":"21","author":"L Kager","year":"2003","unstructured":"Kager L, Zoubek A, P\u00f6tschger U, et al. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol. 2003;21(10):2011\u20138.","journal-title":"J Clin Oncol"},{"key":"1569_CR63","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ebiom.2016.01.011","volume":"4","author":"FF Wei","year":"2016","unstructured":"Wei FF, Drummen NE, Schutte AE, et al. Vitamin K dependent protection of renal function in multi-ethnic population studies. EBioMedicine. 2016;4:162\u20139.","journal-title":"EBioMedicine"},{"issue":"7","key":"1569_CR64","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1093\/ndt\/gfx258","volume":"33","author":"FF Wei","year":"2018","unstructured":"Wei FF, Trenson S, Thijs L, et al. Desphospho-uncarboxylated matrix Gla protein is a novel circulating biomarker predicting deterioration of renal function in the general population. Nephrol Dial Transplant. 2018;33(7):1122\u20138.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"1569_CR65","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.humpath.2013.08.020","volume":"45","author":"N Gonzalez-Roibon","year":"2014","unstructured":"Gonzalez-Roibon N, Faraj SF, Munari E, et al. Comprehensive profile of GATA binding protein 3 immunohistochemical expression in primary and metastatic renal neoplasms. Hum Pathol. 2014;45(2):244\u20138.","journal-title":"Hum Pathol"},{"issue":"5","key":"1569_CR66","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/PGP.0000000000000541","volume":"38","author":"T Terzic","year":"2019","unstructured":"Terzic T, Mills AM, Zadeh S, et al. GATA3 expression in common gynecologic carcinomas: a potential pitfall. Int J Gynecol Pathol. 2019;38(5):485\u201392.","journal-title":"Int J Gynecol Pathol"},{"issue":"10","key":"1569_CR67","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1158\/1078-0432.CCR-04-2236","volume":"11","author":"JL Dennis","year":"2005","unstructured":"Dennis JL, Hvidsten TR, Wit EC, et al. Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm. Clin Cancer Res. 2005;11(10):3766\u201372.","journal-title":"Clin Cancer Res"},{"issue":"12","key":"1569_CR68","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1097\/PAS.0b013e3181f884e8","volume":"34","author":"J Robens","year":"2010","unstructured":"Robens J, Goldstein L, Gown AM, Schnitt SJ. Thyroid transcription factor-1 expression in breast carcinomas. Am J Surg Pathol. 2010;34(12):1881\u20135.","journal-title":"Am J Surg Pathol"},{"key":"1569_CR69","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.humpath.2018.10.009","volume":"84","author":"H Vidarsdottir","year":"2019","unstructured":"Vidarsdottir H, Tran L, Nodin B, et al. Immunohistochemical profiles in primary lung cancers and epithelial pulmonary metastases. Hum Pathol. 2019;84:221\u201330.","journal-title":"Hum Pathol"},{"issue":"7","key":"1569_CR70","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.humpath.2014.02.023","volume":"45","author":"Y Liang","year":"2014","unstructured":"Liang Y, Heitzman J, Kamat AM, et al. Differential expression of GATA-3 in urothelial carcinoma variants. Hum Pathol. 2014;45(7):1466\u201372.","journal-title":"Hum Pathol"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-022-01569-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-022-01569-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-022-01569-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T18:04:16Z","timestamp":1667066656000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-022-01569-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,25]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1569"],"URL":"https:\/\/doi.org\/10.1186\/s13058-022-01569-1","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,25]]},"assertion":[{"value":"13 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with ethical standards and approved by the Ethics Committee of SYSUCC. All study participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"70"}}